Regulation of B-cell entry into the cell cycle

Immunological Reviews

Volumn 224, Issue 1, 2008, Pages 183-200

  Richards, Sabrina ^a   Watanabe, Chie ^a   Santos, Lorna ^a   Craxton, Andrew ^a,b   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bam32; Caspase 6; CD22; Cell cycle; Reactive oxygen species

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; B LYMPHOCYTE RECEPTOR; BIM PROTEIN; CASPASE 6; CD22 ANTIGEN; CD40 ANTIGEN; MEMBRANE PROTEIN; PROTEIN BAM32; PROTEIN BCL 2; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR STIMULATING AGENT;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD22; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTES; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LYMPHOCYTE ACTIVATION; NADPH OXIDASE; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 49249124557     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00652.x     Document Type: Review

References (167)

1. Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 2007 7 : 633 643.
2. Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002 25 : 945 956.
3. Callard R, Hodgkin P. Modeling T- and B-cell growth and differentiation. Immunol Rev 2007 216 : 119 129.
4. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007 2 : 190 202.
5. Gerondakis S, Grumont RJ, Banerjee A. Regulating B-cell activation and survival in response to TLR signals. Immunol Cell Biol 2007 85 : 471 475.
6. Dal Porto JM, Gauld SB, Merrell KT, Mills D, Pugh-Bernard AE, Cambier J. B cell antigen receptor signaling 101. Mol Cell 2004 41 : 599 613.
7. Wu JN, Koretzky GA. The SLP-76 family of adaptor proteins. Semin Immunol 2004 16 : 379 393.
8. Buhl AM, Cambier JC. Co-receptor and accessory regulation of B-cell antigen receptor signal transduction. Immunol Rev 1997 160 : 127 138.
9. Del Nagro CJ, Otero DC, Anzelon AN, Omori SA, Kolla RV, Rickert RC. CD19 function in central and peripheral B-cell development. Immunol Res 2005 31 : 119 131.
10. Nitschke L. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr Opin Immunol 2005 17 : 290 297.
11. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999 13 : 1501 1512.
12. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 2007 102 : 1400 1404.
13. Huang H, Tindall DJ. Commentary. Dynamic FoxO transcription factors. J Cell Sci 2007 120 : 2479 2487.
14. Arellano M, Moreno S. Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol 1997 29 : 559 573.
15. Li WQ, Jiang Q, Aleem E, Kaldis P, Khaled AR, Durum SK. IL-7 promotes T cell proliferation through destabilization of p27Kip1. J Exp Med 2006 203 : 573 582.
16. Stahl M, et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002 168 : 5024 5031.
17. Schmidt M, et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 2002 22 : 7842 7852.
18. Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA. Brief report. Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 2004 104 : 784 787.
19. Grumont RJ, Strasser A, Gerondakis S. B cell growth is controlled by phosphoinositide 3-kinase-dependent induction of Rel/NFκB regulated c-myc transcription. Mol Cell 2002 10 : 1283 1294.
20. Piatelli MJ, et al. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells. J Immunol 2004 172 : 2753 2762.
21. Chiles TC. Regulation and function of cyclin D2 in B lymphocyte subsets. J Immunol 2004 173 : 2901 2907.
22. Solvason N, et al. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int Immunol 2000 12 : 631 638.
23. Lam EW, Glassford J, Banerji L, Thomas NSB, Sicinski P, Klaus GGB. Cyclin D3 compensates for loss of cyclin D2 in mouse B lymphocytes activated via the antigen receptor and CD40. J Biol Chem 2000 275 : 3479 3484.
24. Carman JA, Wechsler-Reya RJ, Monroe JG. Immature stage B cells enter but do not progress beyond the early G1 stage of the cell cycle in response to antigen receptor signaling. J Immunol 1996 156 : 4562 4569.
25. Otipoby KL, et al. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996 384 : 634 637.
26. Niiro H, Clark EA. Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. Immunity 2003 19 : 637 640.
27. Dowler S, Currie RA, Downes CP, Alessi DR. DAPP1: a dual adaptor for phosphotyrosine and 3-phosphoinositides. Biochem J 1999 342 : 7 12.
28. Marshall AJ, et al. A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. J Exp Med 2000 191 : 1319 1332.
29. Marshall AJ, Krahn AK, Ma K, Duronio V, Hou S. TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor. Mol Cell Biol 2002 22 : 5479 5491.
30. Niiro H, Maeda A, Kurosaki T, Clark EA. The B lymphocyte adaptor molecule of 32 kD (Bam32) regulates B cell antigen receptor signaling and cell survival. J Exp Med 2002 195 : 143 149.
31. Allam A, Niiro H, Clark EA, Marshall AJ. The adaptor protein Bam32 regulates Rac1 activation and actin remodeling through a phosphorylation- dependent mechanism. J Biol Chem 2004 279 : 39775 39782.
32. Niiro H, Allam A, Stoddart A, Brodsky FM, Marshall AJ, Clark EA. The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor internalization. J Immunol 2004 173 : 5601 5609.
33. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999 68 : 459 486.
34. Krahn AK, Ma K, Hou S, Duronio V, Marshall AJ. Two distinct waves of membrane-proximal B cell antigen receptor signaling differentially regulated by Src homology 2-containing inositol polyphosphate 5-phosphatase. J Immunol 2004 172 : 331 339.
35. March ME, Ravichandran K. Regulation of the immune response by SHIP. Semin Immunol 2002 14 : 37 47.
36. Han A, Saijo K, Mecklenbrauker I, Tarakhovsky A, Nussenzweig MC. Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity 2003 19 : 621 632.
37. Fournier E, et al. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr Biol 2003 13 : 1858 1866.
38. Marshall AJ, Zhang T, Al-Alwan M. Regulation of B-lymphocyte activation by the PH domain adaptor protein Bam32/DAPP1. Biochem Soc Trans 2007 35 : 181 182.
39. Schmid I, Cole SW, Korin YD, Zack JA, Giorgi JV. Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence. Cytometry 2000 39 : 108 116.
40. Clark EA, Richards S, Santos L. Regulation of B cell entry into cell cycle by superoxide and CD22. Biology of B Cells in Health and Disease. Keystone Symposia 2007 abstract 173 : 77.
41. Monteiro HP, Stern A. Redox modulation of tyrosine phosphorylation- dependent signal transduction pathways. Free Radic Biol Med 1996 21 : 323 333.
42. Chiarugi P, Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 2003 28 : 509 514.
43. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 2005 17 : 183 189.
44. Meng TC, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 2002 9 : 387 399.
45. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002 3 : 1129 1134.
46. Sumimoto H, Miyano K, Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 2005 338 : 677 686.
47. Kanai F, et al. The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat Cell Biol 2001 3 : 675 678.
48. Morel F, et al. The O2- generating oxidase of B lymphocytes: Epstein-Barr virus-immortalized B lymphocytes as a tool for the identification of defective components of the oxidase in chronic granulomatous disease. Biochim Biophys Acta 1993 1182 : 101 109.
49. Schieven GL, Kirihara JM, Burg DL, Geahlen RL, Ledbetter JA. p72syk tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+ signals. J Biol Chem 1993 268 : 16688 16692.
50. Singh DK, Kumar D, Siddiqui Z, Basu SK, Kumar V, Rao KV. The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 2005 121 : 281 293.
51. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell 2005 121 : 667 670.
52. Pollock JD, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995 9 : 202 209.
53. Richards S, Clark EA. Superoxide production influences cell cycle entry downstream of BCR ligation. Biology of B Cells in Health and Disease. Keystone Symposia 2007 abstract 358 : 107.
54. Hibbs ML, et al. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med 2002 196 : 1593 1604.
55. Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 1997 7 : 69 81.
56. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994 367 : 425 428.
57. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001 106 : 255 258.
58. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003 367 : 984 993.
59. Dubois B, et al. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol 1998 161 : 2223 2231.
60. Balazs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002 17 : 341 352.
61. Litinskiy MB, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002 3 : 822 829.
62. Craxton A, Magaletti D, Ryan EJ, Clark EA. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 2003 101 : 4464 4471.
63. Hanada T, et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 2003 19 : 437 450.
64. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003 19 : 225 234.
65. Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP, Clark EA. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 1996 157 : 4363 4370.
66. Wykes M, MacPherson G. Dendritic cell-B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 2000 100 : 1 352.
67. Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005 23 : 503 514.
68. Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 2006 312 : 1672 1676.
69. Santos L, Draves KE, Boton M, Grewal PK, Marth JD, Clark EA. Dendritic cell-dependent inhibition of B cell proliferation requires CD22. J Immunol 2008 180 : 4561 4569.
70. Hawiger D, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001 194 : 769 779.
71. Steinman RM, Hawiger D, Nuusenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21 : 685 711.
72. Law CL, et al. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation. J Exp Med 1996 183 : 547 560.
73. Cornall RJ, Goodnow CC, Cyster JG. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway. Curr Top Microbiol Immunol 1999 244 : 57 68.
74. Nitschke L, Tsubata T. Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol 2004 25 : 543 550.
75. Hennet T, Chui D, Paulson JC, Marth JD. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 1998 95 : 4504 4509.
76. Law CL, Aruffo A, Chandran KA, Doty RT, Clark EA. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J Immunol 1995 155 : 3368 3376.
77. Cyster JG, Goodnow CC. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 1997 6 : 509 517.
78. Grewal PK, et al. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling. Mol Cell Biol 2006 26 : 4970 4981.
79. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007 7 : 255 266.
80. Poe JC, et al. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol 2004 5 : 1078 1087.
81. Jin PL, McLean PA, Neel BG, Wortis HH. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med 2002 195 : 1199 1205.
82. Kelm S, Gerlach J, Grossmer R, Danzer CP, Nitschke L. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J Exp Med 2002 195 : 1207 1213.
83. Han S, Collins BE, Bengtson P, Paulson JC. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat Chem Biol 2005 155 : 93 97.
84. Collins BE, Smith BA, Bengtson P, Paulson JC. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat Immunol 2006 7 : 199 206.
85. Pillai S, Cariappa A, Moran ST. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev 2004 197 : 206 218.
86. Casola S, et al. B cell receptor signal strength determines B cell fate. Nat Immunol 2004 5 : 317 327.
87. Carsetti R, Kohler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995 181 : 2129 2140.
88. Waldschmidt TJ, Noelle RJ. Long live the mature B cell - a baffling mystery resolved. Science 2001 293 : 2012 2013.
89. Collins BE, Blixt O, DeSieno AR, Bovin N, Marth JD, Paulson JC. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci USA 2004 101 : 6104 6109.
90. Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA. CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci USA 1993 90 : 3236 3240.
91. Tuscano JM, Riva A, Toscano SN, Tedder TF, Kehrl JH. CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade. Blood 1999 94 : 1382 1392.
92. Lanoue A, Batista FD, Stewart M, Neuberger MS. Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur J Immunol 2002 32 : 348 355.
93. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005 5 : 189 200.
94. Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003 4 : 410 415.
95. Chen L, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005 17 : 393 403.
96. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002 2 : 183 192.
97. Bouillet P, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999 286 : 1735 1738.
98. Bouillet P, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002 415 : 922 926.
99. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003 198 : 1119 1126.
100. Craxton A, Draves KE, Gruppi A, Clark EA. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 2005 202 : 1363 1374.
101. Lesley R, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004 20 : 441 453.
102. Goodyear CS, Corr M, Sugiyama F, Boyle DL, Silverman GJ. Bim is required for superantigen-mediated B cell death. J Immunol 2007 178 : 2636 2640.
103. Brunner C, Marinkovic D, Klein J, Samardzic T, Nitschke L, Wirth T. B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB. 1/OBF.1-deficient mice. J Exp Med 2003 197 : 1205 1211.
104. Tardivel A, et al. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Eur J Immunol 2004 34 : 509 518.
105. Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 2001 197 : 645 653.
106. Bouillet P, Robati M, Bath M, Strasser A. Polycystic kidney disease prevented by transgenic RNA interference. Cell Death Differ 2005 12 : 831 833.
107. O'Reilly LA, Huang DC, Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 1996 15 : 6979 6990.
108. O'Reilly LA, Harris AW, Tarlinton DM, Corcoran LM, Strasser A. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol 1997 159 : 2301 2311.
109. Linette GP, Li Y, Roth K, Korsmeyer SJ. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 1996 93 : 9545 9552.
110. Vairo G, et al. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol 2000 20 : 4745 4753.
111. Greider C, Chattopadhyay A, Parkhurst C, Yang E. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Oncogene 2002 21 : 7765 7775.
112. Craxton A, Draves KE, Clark EA. Bim promotes BCR-induced entry of B cells into the cell cycle. Eur J Immunol 2007 37 : 2715 2722.
113. Morishima N, Nakanishi K, Tsuchiya K, Shibata T, Seiwa E. Translocation of Bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis. J Biol Chem 2004 279 : 50375 50381.
114. Davis MC, Distelhorst CW. Live free or die: an immature T cell decision encoded in distinct Bcl-2 sensitive and insensitive Ca2+ signals. Cell Cycle 2006 5 : 1171 1174.
115. Cante-Barrett K, Gallo EM, Winslow MM, Crabtree GR. Thymocyte negative selection is mediated by protein kinase C-and Ca2+-dependent transcriptional induction of Bim of cell death. J Immunol 2006 176 : 2299 2306.
116. Marechal Y, et al. Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Proc Natl Acad Sci USA 2007 104 : 13978 13983.
117. Alnemri ES, et al. Human ICE/CED-3 protease nomenclature. Cell 1996 87 : 171.
118. Graves JD, Craxton A, Clark EA. Modulation and function of caspase pathways in B lymphocytes. Immunol Rev 2004 197 : 129 146.
119. Kuranaga E, Miura M. Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol 2007 17 : 135 144.
120. Abraham MC, Shaham S. Death without caspases, caspases without death. Trends Cell Biol 2004 14 : 184 193.
121. Wang ZB, Liu YQ, Cui YF. Pathways to caspase activation. Cell Biol Int 2005 29 : 489 496.
122. Luthi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ 2007 14 : 641 650.
123. Timmer JC, Salvesen GS. Caspase substrates. Cell Death Differ 2007 14 : 66 72.
124. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007 14 : 44 55.
125. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 2006 6 : 308 317.
126. Su H, et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005 305 : 1465 1468.
127. Bidere N, Snow AL, Sakai K, Zheng L, Lenardo MJ. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. Curr Biol 2006 16 : 1666 1671.
128. Salmena L, et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003 17 : 883 895.
129. Salmena L, Hakem R. Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med 2005 202 : 727 732.
130. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S. Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 2006 176 : 4520 4524.
131. Beisner DR, Ch'en IL, Kolla RV, Hoffmann A, Hedrick SM. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol 2005 175 : 3469 3473.
132. Lemmers B, et al. Essential role for caspase-8 in Toll-like receptors and NFκB signaling. J Biol Chem 2007 282 : 7416 7423.
133. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004 4 : 499 511.
134. Woo M, et al. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat Immunol 2003 4 : 1016 1022.
135. Park JA, Kim KW, Kim SI, Lee SK. Caspase 3 specifically cleaves p21WAF1/CIP1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells. Eur J Biochem 1998 257 : 242 248.
136. Gervais JL, Seth P, Zhang H. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J Biol Chem 1998 273 : 19207 19212.
137. Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell 2007 129 : 665 679.
138. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992 71 : 505 514.
139. LaBaer J, et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997 11 : 847 862.
140. Weiss RH, Joo A, Randour C. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 2000 275 : 10285 10290.
141. Cheng M, et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999 18 : 1583.
142. Olson NE, Graves JD, Shu GL, Ryan EJ, Clark EA. Caspase activity is required for stimulated B lymphocytes to enter the cell cycle. J Immunol 2003 170 : 6065 6072.
143. Werz O, et al. Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells. Proc Natl Acad Sci USA 2005 102 : 13164 13169.
144. Zheng TS, et al. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med 2000 6 : 1241 1247.
145. D'Sa C, et al. Caspase regulation of genotoxin-induced neural precursor cell death. J Neurosci Res 2003 74 : 435 445.
146. Watanabe C, Shu GL, Zheng TS, Flavell RA, Clark EA. Caspase-6 regulates B cell activation and differentiation into plasma cells. Under revision 2008.
147. Chen-Kiang S. Cell-cycle control of plasma cell differentiation and tumorigenesis. Immunol Rev 2003 164 : 39 47.
148. Underhill GH, George D, Bremer EG, Kansas GS. Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood 2003 101 : 4013 4021.
149. Galande S, Dickinson LA, Mian IS, Sikorska M, Kohwi-Shigematsu T. SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol Cell Biol 2001 21 : 5591 5604.
150. Eymin B, et al. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity. Oncogene 1999 18 : 4847.
151. Cohen LY, et al. Notch1 antiapoptotic activity is abrogated by caspase cleavage in dying T lymphocytes. Cell Death Differ 2005 12 : 243 254.
152. Nyormoi O, Wang Z, Doan D, Ruiz M, McConkey D, Bar-Eli M. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells. Mol Cell Biol 2001 21 : 4856 4867.
153. Takahashi A, et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 1996 93 : 8395 8400.
154. Rokudai S, Fujita N, Hashimoto Y, Tsuruo T. Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J Cell Physiol 2000 182 : 290 296.
155. Chau BN, Wangm J. Y. Coordinated regulation of life and death by RB. Nat Rev Cancer 2003 3 : 130 138.
156. Skapek SX, Pan YR, Lee EY. Regulation of cell lineage specification by the retinoblastoma tumor suppressor. Oncogene 2006 25 : 5268 5276.
157. De Vos J, et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 2002 21 : 6848 6857.
158. Santambrogio L, Potolicchio I, Fessler SP, Wong SH, Raposo G, Strominger JL. Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells. Nat Immunol 2005 6 : 1020 1028.
159. Hardy RR. B-1 B cell development. J Immunol 2006 177 : 2749 2754.
160. Fleming HE, Paige CJ. Cooperation between IL-7 and the pre-B cell receptor: a key to B cell selection. Semin Immunol 2002 14 : 423 430.
161. O'Neill RM, Hassan J, Reen D. J. IL-7-regulated homeostatic maintenance of recent thymic emigrants in association with caspase-mediated cell proliferation and apoptotic cell death. J Immunol 2003 170 : 4524 4531.
162. Fischer SF, Bouillet P, O'Donnell K, Light A, Tarlinton DM, Strasser A. Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood 2007 110 : 3978 3984.
163. Liu YJ, Oldfield S, MacLennan IC. Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 1988 182 : 355 362.
164. Clark EA, Ledbetter JA. How does B cell depletion therapy work, and how can it be improved? Ann Rheum Dis 2005 64 (Suppl. 4) : iv77 iv80.
165. Gray D, Gray M, Barr T. Innate responses of B cells. Eur J Immunol 2007 37 : 3304 3310.
166. Tam CS, Keating MJ. Chemoimmunotherapy of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007 202 : 479 498.
167. Pathan NI, Chu P, Hariharan K, Cheney C, Molina A, Byrd J. Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. Blood 2008 111 : 1594 1602.